Literature DB >> 10990242

Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis.

F De Benedetti1, M Vivarelli, P Pignatti, M Oliveri, M Massa, A Pistorio, A Martini.   

Abstract

OBJECTIVE: To measure circulating levels of soluble E-selectin (sE-selectin), sP-selectin, and soluble intercellular adhesion molecule-1 (sICAM-1) in patients with active juvenile idiopathic arthritides (JIA), and to evaluate their correlation with disease activity variables and cytokine levels.
METHODS: Serum levels of sE-selectin, sP-selectin, and sICAM-1 were measured by ELISA in 42 patients with JIA and in 15 healthy controls.
RESULTS: Circulating levels of sE-selectin and sICAM-1, but not sP-selectin, were significantly elevated in patients with active systemic JIA. In patients with active polyarticular or pauciarticular JIA serum levels of sE-selectin. sP-selectin, and sICAM-1 were comparable to those of controls. In patients with systemic JIA, levels of sE-selectin and sICAM-1 were significantly correlated with levels of soluble tumor necrosis factor receptor 2 (sTNFR2), but not with those of interleukin 6 (IL-6) or IL-1beta.
CONCLUSION: Patients with active systemic JIA have elevated circulating levels of sE-selectin and sICAM-1. The correlation with sTNFR2, together with previous data on the TNF system in systemic JIA. suggests that TNF activated endothelial cells are the source of sE-selectin and sICAM-1 in this disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990242

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

2.  Cytokines and juvenile idiopathic arthritis.

Authors:  Patricia Woo
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

3.  Assessment of vascular function in systemic onset juvenile idiopathic arthritis.

Authors:  Betul Sozeri; Basak Yildiz Atikan; Kadriye Ozdemir; Sevgi Mir
Journal:  Clin Rheumatol       Date:  2016-04-13       Impact factor: 2.980

4.  Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis.

Authors:  Bradley J Bloom; Mieko Toyoda; Anna Petrosian; Stanley Jordan
Journal:  Rheumatol Int       Date:  2006-12-13       Impact factor: 3.580

5.  Systemic arthritis in children: a review of clinical presentation and treatment.

Authors:  R Gurion; T J A Lehman; L N Moorthy
Journal:  Int J Inflam       Date:  2011-12-25

Review 6.  Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?

Authors:  Faekah Gohar; Christoph Kessel; Miha Lavric; Dirk Holzinger; Dirk Foell
Journal:  Arthritis Res Ther       Date:  2016-07-13       Impact factor: 5.156

7.  Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission.

Authors:  Inmaculada Concepción Aranda-Valera; Iván Arias de la Rosa; Rosa Roldán-Molina; María Del Carmen Ábalos-Aguilera; Carmen Torres-Granados; Alejandra Patiño-Trives; María Luque-Tevar; Alejandro Ibáñez-Costa; Rocío Guzmán-Ruiz; María Del Mar Malagón; Alejandro Escudero-Contreras; Chary López-Pedrera; Eduardo Collantes-Estévez; Nuria Barbarroja
Journal:  Pediatr Rheumatol Online J       Date:  2020-07-14       Impact factor: 3.054

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.